<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34296525</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>185</Volume>
            <Issue>12</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>American journal of medical genetics. Part A</Title>
          <ISOAbbreviation>Am J Med Genet A</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Homozygous GLI3 variants observed in three unrelated patients presenting with syndromic polydactyly.</ArticleTitle>
        <Pagination>
          <StartPage>3831</StartPage>
          <EndPage>3837</EndPage>
          <MedlinePgn>3831-3837</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.62426</ELocationID>
        <Abstract>
          <AbstractText>Polydactyly is a hallmark of GLI3 pathogenic variants, with Greig cephalopolysyndactyly syndrome and Pallister-Hall syndrome being the two main associated clinical presentations. Homozygous GLI3 variants are rare instances in the literature, and mendelian dominance is the accepted framework for GLI3-related diseases. Herein, we report three unrelated probands, presenting with polydactyly, and homozygous variants in the GLI3 gene. First, a 10-year-old girl, whose parents were first-degree cousins, presented with bilateral postaxial polydactyly of the hands, developmental delay and multiple malformations. Second, a male newborn, whose parents were first-degree cousins, presented with isolated bilateral postaxial polysyndactyly of the hands and the feet. Third, an adult male, whose parents were first-degree cousins, had bilateral mesoaxial polydactyly of the hands, with severe intellectual disability and multiple malformations. All three probands carried homozygous GLI3 variants. Strikingly, the parents also carried the child's variant, in the heterozygous state, without any clinical sign of GLI3 disease. Given the clinical presentation of our patients, the rarity and predicted high pathogenicity of the variants observed, and the absence of other pathogenic variants, we suggest that these GLI3 homozygous variants are causal. Moreover, the parents were heterozygous for the observed variants, but were clinically unremarkable, suggesting that these variants are hypomorphic alleles.</AbstractText>
          <CopyrightInformation>© 2021 Wiley Periodicals LLC.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>El Mouatani</LastName>
            <ForeName>Ahmed</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-0776-4380</Identifier>
            <AffiliationInfo>
              <Affiliation>Service Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Van Winckel</LastName>
            <ForeName>Géraldine</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0003-1808-4276</Identifier>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Génétique, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zaafrane-Khachnaoui</LastName>
            <ForeName>Khaoula</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0002-1272-4327</Identifier>
            <AffiliationInfo>
              <Affiliation>Service de Génétique Médicale, CHU de Nice, Hôpital de l'Archet II, Nice, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Whalen</LastName>
            <ForeName>Sandra</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-9156-5047</Identifier>
            <AffiliationInfo>
              <Affiliation>Unité Fonctionnelle de Génétique Clinique, Centre de Référence Maladies Rares Anomalies du développement et syndromes malformatifs, Hôpital Armand Trousseau, Assistance Publique - Hôpitaux de Paris, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Achaiaa</LastName>
            <ForeName>Amale</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Service Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaltenbach</LastName>
            <ForeName>Sophie</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-6544-357X</Identifier>
            <AffiliationInfo>
              <Affiliation>Service Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM UMR 1163, Université de Paris, Imagine Institute, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Superti-Furga</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-3543-7531</Identifier>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Génétique, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vekemans</LastName>
            <ForeName>Michel</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-2564-1296</Identifier>
            <AffiliationInfo>
              <Affiliation>Service Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fodstad</LastName>
            <ForeName>Heidi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Génétique, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Giuliano</LastName>
            <ForeName>Fabienne</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">0000-0001-5197-8883</Identifier>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Génétique, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Attie-Bitach</LastName>
            <ForeName>Tania</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">0000-0002-1155-3626</Identifier>
            <AffiliationInfo>
              <Affiliation>Service Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>INSERM UMR 1163, Université de Paris, Imagine Institute, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>07</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Med Genet A</MedlineTA>
        <NlmUniqueID>101235741</NlmUniqueID>
        <ISSNLinking>1552-4825</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C065683">GLI3 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000074290">Zinc Finger Protein Gli3</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017689" MajorTopicYN="N">Polydactyly</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074290" MajorTopicYN="N">Zinc Finger Protein Gli3</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">GLI3</Keyword>
        <Keyword MajorTopicYN="Y">Greig cephalopolysyndactyly</Keyword>
        <Keyword MajorTopicYN="Y">OFD syndromes</Keyword>
        <Keyword MajorTopicYN="Y">Pallister-Hall</Keyword>
        <Keyword MajorTopicYN="Y">polydactyly</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>23</Day>
          <Hour>7</Hour>
          <Minute>16</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34296525</ArticleId>
        <ArticleId IdType="doi">10.1002/ajmg.a.62426</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Al-Hamed, M. H., Alsahan, N., Rice, S. J., Edwards, N., Nooreddeen, E., Alotaibi, M., Kurdi, W., Alnemer, M., Altaleb, N., Ali, W., Al-Numair, N., Almejaish, N., Sayer, J. A., &amp; Imtiaz, F. (2019). Bialleleic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families. Pediatric Nephrology (Berlin, Germany), 34, 1615-1623.</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Qattan, M. M., Shamseldin, H. E., Salih, M. A., &amp; Alkuraya, F. S. (2017). GLI3-related polydactyly: a review. Clinical Genetics, 92(5), 457-466. http://dx.doi.org/10.1111/cge.12952.</Citation>
        </Reference>
        <Reference>
          <Citation>Avila, M., Gigot, N., Aral, B., Callier, P., Gautier, E., Thevenon, J., Pasquier, L., Lopez, E., Gueneau, L., Duplomb, L., Goldenberg, A., Baumann, C., Cormier, V., Marlin, S., Masurel-Paulet, A., Huet, F., Attié-Bitach, T., Faivre, L., &amp; Thauvin-Robinet, C. (2011). GLI3 is rarely implicated in OFD syndromes with midline abnormalities. Human Mutation, 32, 1332-1333.</Citation>
        </Reference>
        <Reference>
          <Citation>Biesecker, L. G. (1993). Pallister-Hall Syndrome. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, K. Stephens, &amp; A. Amemiya (Eds.), GeneReviews®. University of Washington, Seattle.</Citation>
        </Reference>
        <Reference>
          <Citation>Biesecker, L. G. (2008). The Greig cephalopolysyndactyly syndrome. Orphanet Journal of Rare Diseases, 3(1), 10. http://dx.doi.org/10.1186/1750-1172-3-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Bruel, A.-L., Franco, B., Duffourd, Y., Thevenon, J., Jego, L., Lopez, E., Deleuze, J.-F., Doummar, D., Giles, R. H., Johnson, C. A., Huynen, M. A., Chevrier, V., Burglen, L., Morleo, M., Desguerres, I., Pierquin, G., Doray, B., Gilbert-Dussardier, B., Reversade, B., … Thauvin-Robinet, C. (2017). Fifteen years of research on oral-facial-digital syndromes: from 1 to 16 causal genes. Journal of Medical Genetics, 54, 371-380.</Citation>
        </Reference>
        <Reference>
          <Citation>Carballo, G. B., Honorato, J. R., de Lopes, G. P. F., &amp; de SE, S. T. C. L. (2018). A highlight on Sonic hedgehog pathway. Cell Communication and Signaling, 16, 11.</Citation>
        </Reference>
        <Reference>
          <Citation>Démurger, F., Ichkou, A., Mougou-Zerelli, S., Le Merrer, M., Goudefroye, G., Delezoide, A.-L., Quélin, C., Manouvrier, S., Baujat, G., Fradin, M., Pasquier, L., Megarbané, A., Faivre, L., Baumann, C., Nampoothiri, S., Roume, J., Isidor, B., Lacombe, D., Delrue, M.-A., … Attie-Bitach, T. (2015). New insights into genotype-phenotype correlation for GLI3 mutations. European Journal of Human Genetics, 23, 92-102.</Citation>
        </Reference>
        <Reference>
          <Citation>Elson, E., Perveen, R., Donnai, D., Wall, S., &amp; Black, G. C. M. (2002). De novo GLI3 mutation in acrocallosal syndrome: Broadening the phenotypic spectrum of GLI3 defects and overlap with murine models. Journal of Medical Genetics, 39, 804-806.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnston, J. J., Olivos-Glander, I., Killoran, C., Elson, E., Turner, J. T., Peters, K. F., Abbott, M. H., Aughton, D. J., Aylsworth, A. S., Bamshad, M. J., Booth, C., Curry, C. J., David, A., Dinulos, M. B., Flannery, D. B., Fox, M. A., Graham, J. M., Grange, D. K., Guttmacher, A. E., …, Biesecker, L. G. (2005). Molecular and clinical analyses of greig cephalopolysyndactyly and pallister-hall syndromes: Robust phenotype prediction from the type and position of GLI3 mutations. The American Journal of Human Genetics, 76(4), 609-622. http://dx.doi.org/10.1086/429346.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnston, J. J., Sapp, J. C., Turner, J. T., Amor, D., Aftimos, S., Aleck, K. A., Bocian, M., Bodurtha, J. N., Cox, G. F., Curry, C. J., Day, R., Donnai, D., Field, M., Fujiwara, I., Gabbett, M., Gal, M., Graham, J. M., Hedera, P., Hennekam, R. C. M., … Biesecker, L. G. (2010). Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations. Human Mutation, 31, 1142-1154.</Citation>
        </Reference>
        <Reference>
          <Citation>Kang, S., Graham, J. M., Olney, A. H., &amp; Biesecker, L. G. (1997). GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nature Genetics, 15(3), 266-268. http://dx.doi.org/10.1038/ng0397-266.</Citation>
        </Reference>
        <Reference>
          <Citation>Kariminejad, A., Ghaderi-Sohi, S., Keshavarz, E., Hashemi, S. A., Parsimehr, E., Szenker-Ravi, E., Khatoo, M., Faraji Zonooz, M., Reversade, B., Najmabadi, H., &amp; Hennekam, R. C. (2020). A GLI3 variant leading to polydactyly in heterozygotes and Pallister-Hall-like syndrome in a homozygote. Clinical Genetics, 97, 915-919.</Citation>
        </Reference>
        <Reference>
          <Citation>Mellerio, J. E., Ashton, G. H., Mohammedi, R., Lyon, C. C., Kirby, B., Harman, K. E., Salas-Alanis, J. C., Atherton, D. J., Harrison, P. V., Griffiths, W. A., Black, M. M., Eady, R. A., &amp; McGrath, J. A. (1999). Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa. The Journal of Investigative Dermatology, 112, 984-987.</Citation>
        </Reference>
        <Reference>
          <Citation>Monies, D., Maddirevula, S., Kurdi, W., Alanazy, M. H., Alkhalidi, H., Al-Owain, M., Sulaiman, R. A., Faqeih, E., Goljan, E., Ibrahim, N., Abdulwahab, F., Hashem, M., Abouelhoda, M., Shaheen, R., Arold, S. T., &amp; Alkuraya, F. S. (2017). Autozygosity reveals recessive mutations and novel mechanisms in dominant genes: Implications in variant interpretation. Genetics in Medicine, 19, 1144-1150.</Citation>
        </Reference>
        <Reference>
          <Citation>Perkins, E., Suminaite, D., &amp; Jackson, M. (2016). Cerebellar ataxias: β-III spectrin's interactions suggest common pathogenic pathways. The Journal of Physiology, 594, 4661-4676.</Citation>
        </Reference>
        <Reference>
          <Citation>Ruiz-Perez, V. L., Ide, S. E., Strom, T. M., Lorenz, B., Wilson, D., Woods, K., King, L., Francomano, C., Freisinger, P., Spranger, S., Marino, B., Dallapiccola, B., Wright, M., Meitinger, T., Polymeropoulos, M. H., &amp; Goodship, J. (2000). Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nature Genetics, 24, 283-286.</Citation>
        </Reference>
        <Reference>
          <Citation>Speksnijder, L., Cohen-Overbeek, T. E., Knapen, M. F. C. M., Lunshof, S. M., Hoogeboom, A. J. M., van den Ouwenland, A. M., de Coo, I. F. M., Lequin, M. H., Bolz, H. J., Bergmann, C., Biesecker, L. G., Willems, P. J., &amp; Wessels, M. W. (2013). A de novo GLI3 mutation in a patient with acrocallosal syndrome. American Journal of Medical Genetics. Part A, 161, 1394-1400.</Citation>
        </Reference>
        <Reference>
          <Citation>Umair, M., Ahmad, F., Bilal, M., Ahmad, W., &amp; Alfadhel, M. (2018). Clinical genetics of polydactyly: An updated review. Frontiers in Genetics, 9, 447.</Citation>
        </Reference>
        <Reference>
          <Citation>Umair, M., Wasif, N., Albalawi, A. M., Ramzan, K., Alfadhel, M., Ahmad, W., &amp; Basit, S. (2019). Exome sequencing revealed a novel loss-of-function variant in the GLI3 transcriptional activator 2 domain underlies nonsyndromic postaxial polydactyly. Molecular Genetics &amp; Genomic Medicine, 7, e00627.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilde, A. A. M., &amp; Amin, A. S. (2018). Clinical spectrum of SCN5A mutations: Long QT syndrome, Brugada syndrome, and cardiomyopathy. Clinical Electrophysiology, 4, 569-579.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
